Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma
Am Health Drug Benefits
.
2015 Mar;8(Spec Feature):96-100.
Author
Lisa A Raedler
PMID:
26629272
PMCID:
PMC4665064
No abstract available